Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AGBAWNASDAQ:AGNCONASDAQ:AGNCPNASDAQ:DMAAU On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAGBAWAGBA Group$0.09+2.7%$0.09$0.01▼$0.45N/AN/A83,633 shs37,957 shsAGNCOAGNC Investment$25.07-1.3%$25.37$23.68▼$25.95N/AN/A40,928 shs18,732 shsAGNCPAGNC Investment$24.79-1.3%$24.94$23.37▼$25.48N/AN/A49,887 shs18,065 shsDMAAUDrugs Made in America Acquisition$10.38+0.6%$10.28$10.00▼$10.82N/AN/A46,926 shs338 shsReduce the RiskMarket downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAGBAWAGBA Group0.00%+8.30%+0.58%-20.55%-67.99%AGNCOAGNC Investment-1.21%-1.51%+0.47%+0.95%+1.11%AGNCPAGNC Investment-0.95%-0.83%+1.05%+0.24%+4.06%DMAAUDrugs Made in America Acquisition-0.77%+0.10%+0.19%+1.98%+1,031,999,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAGBAWAGBA GroupN/AN/AN/AN/AN/AN/AN/AN/AAGNCOAGNC InvestmentN/AN/AN/AN/AN/AN/AN/AN/AAGNCPAGNC InvestmentN/AN/AN/AN/AN/AN/AN/AN/ADMAAUDrugs Made in America AcquisitionN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAGBAWAGBA Group 0.00N/AN/AN/AAGNCOAGNC Investment 0.00N/AN/AN/AAGNCPAGNC Investment 0.00N/AN/AN/ADMAAUDrugs Made in America Acquisition 0.00N/AN/AN/ACompare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAGBAWAGBA Group$38.55MN/AN/AN/AN/AN/AAGNCOAGNC Investment$584MN/AN/AN/AN/AN/AAGNCPAGNC Investment$584MN/AN/AN/AN/AN/ADMAAUDrugs Made in America AcquisitionN/AN/AN/AN/AN/AN/ACompare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAGBAWAGBA GroupN/AN/A0.00∞N/AN/AN/AN/AN/AAGNCOAGNC InvestmentN/AN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)AGNCPAGNC InvestmentN/AN/A0.00∞N/AN/AN/AN/A7/21/2025 (Estimated)DMAAUDrugs Made in America AcquisitionN/AN/A0.00∞N/AN/AN/AN/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAGBAWAGBA GroupN/AN/AN/AN/AN/AAGNCOAGNC Investment$1.636.50%N/AN/AN/AAGNCPAGNC Investment$1.536.17%N/AN/AN/ADMAAUDrugs Made in America AcquisitionN/AN/AN/AN/AN/ALatest DMAAU, AGBAW, AGNCP, and AGNCO DividendsAnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date6/12/2025AGNCOAGNC Investmentquarterly$0.60138%7/1/20257/1/20257/15/20256/12/2025AGNCPAGNC Investment$0.58267/1/20257/1/20257/15/2025(Data available from 1/1/2013 forward)Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAGBAWAGBA GroupN/AAGNCOAGNC InvestmentN/AAGNCPAGNC InvestmentN/ADMAAUDrugs Made in America AcquisitionN/AInsider OwnershipCompanyInsider OwnershipAGBAWAGBA GroupN/AAGNCOAGNC InvestmentN/AAGNCPAGNC InvestmentN/ADMAAUDrugs Made in America AcquisitionN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAGBAWAGBA Group152N/AN/ANot OptionableAGNCOAGNC Investment50N/AN/ANot OptionableAGNCPAGNC Investment50N/AN/ANot OptionableDMAAUDrugs Made in America Acquisition2N/AN/AN/ADMAAU, AGBAW, AGNCP, and AGNCO HeadlinesRecent News About These CompaniesDMAAU Drugs Made In America Acquisition Corp. UnitsJune 7, 2025 | seekingalpha.comDMAA Drugs Made In America Acquisition Corp.March 22, 2025 | seekingalpha.comDrugs Made In America Acquisition CorpMarch 12, 2025 | morningstar.comMA new era of Made in America drug manufacturingFebruary 28, 2025 | msn.comDrugs Made in America Acquisition Corp. Announces Advisory TeamFebruary 24, 2025 | gurufocus.comDrugs Made in America Acquisition Corp. Forms Advisory Team to Pursue Pharmaceutical Business AcquisitionsFebruary 24, 2025 | quiverquant.comQDrugs Made In America Acquisition Corp. UnitsFebruary 20, 2025 | fxempire.comFDrugs Made In America Acquisition Corp. Announces Closing of Full Exercise of IPO Over-Allotment OptionFebruary 18, 2025 | markets.businessinsider.comDrugs Made In America Acquisition Corp. Units (DMAAU)January 30, 2025 | finance.yahoo.comDrugs Made In America Acquisition Corp. Announces Closing of $200,000,000 Initial Public OfferingJanuary 30, 2025 | markets.businessinsider.comDrugs Made In America Acquisition Corp. Announces Pricing of $200,000,000 Initial Public OfferingJanuary 27, 2025 | markets.businessinsider.comDrugs Made In America Acquisition Corp Share Price (DMAAU.US)January 16, 2025 | lse.co.ukDrugs Made In America Acquisition Corporation Cons of 1 Shs + 1-10 RtJanuary 12, 2025 | markets.businessinsider.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeDMAAU, AGBAW, AGNCP, and AGNCO Company DescriptionsAGBA Group NASDAQ:AGBAW$0.09 +0.00 (+2.75%) As of 06/30/2025AGBA Group Holding Limited together with its subsidiaries provides wealth management and healthcare institution services in Hong Kong. The company operates through Platform Business, Distribution Business, Healthcare Business, and Fintech Business segments. The Platform Business segment operates as a financial supermarket that offers financial products, such as life insurance, pensions, property-casualty insurance, stock brokerage, mutual funds, money lending, and real estate agency services. This segment serves banks, financial institutions, family offices, brokers, and individual independent financial advisors. The Distribution Business segment provides personal financial advisory services; and financial services and products, including long-term life insurance, savings, and mortgages. The Healthcare Business segment operates self-operated medical centers and a network of healthcare service providers in the Hong Kong and Macau region. The Fintech Business segment provides assets and businesses in Europe and Hong Kong. The Fintech Business segment manages financial technology investments with a spectrum of services and value-added information in health, insurance, investments, and social sharing. The company was formerly known as AGBA Acquisition Limited and changed its name to AGBA Group Holding Limited. AGBA Group Holding Limited was founded in 1993 and is headquartered in Wan Chai, Hong Kong.AGNC Investment NASDAQ:AGNCO$25.06 -0.34 (-1.32%) As of 12:34 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.AGNC Investment Corp. provides private capital to housing market in the United States. It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as American Capital Agency Corp. and changed its name to AGNC Investment Corp. in September 2016. AGNC Investment Corp. was incorporated in 2008 and is headquartered in Bethesda, Maryland.AGNC Investment NASDAQ:AGNCP$24.79 -0.32 (-1.27%) As of 12:57 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.AGNC Investment Corp. provides private capital to housing market in the United States. It invests in residential mortgage pass-through securities and collateralized mortgage obligations for which the principal and interest payments are guaranteed by the United States government-sponsored enterprise or by the United States government agency. The company qualifies as a real estate investment trust for federal income tax purposes. It generally would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was formerly known as American Capital Agency Corp. and changed its name to AGNC Investment Corp. in September 2016. AGNC Investment Corp. was incorporated in 2008 and is headquartered in Bethesda, Maryland.Drugs Made in America Acquisition NASDAQ:DMAAU$10.38 +0.06 (+0.58%) As of 10:02 AM EasternDrugs Made In America Acquisition Corp. is a blank check company newly incorporated in the Cayman Islands as an exempted company incorporated for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses. To date, our efforts have been limited to organizational activities as well as activities related to this offering. We have not selected any specific business combination target and we have not, nor has anyone on our behalf, engaged in any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with us. While we may pursue a business combination target in any business, industry or geographical location, we intend to focus our search for businesses in the pharmaceutical industry. Our executive offices are located at 1 East Broward Boulevard, Suite 700, Fort Lauderdale, FL 33301 and our telephone number is (954) 870-3099. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas 2 Under the Radar Space & Defense Stocks With Huge Potential Palantir’s $100M Nuclear OS Pact Boosts Bullish Case Joby Stock Soars as Piloted Flights in Dubai Signal a New Era Tesla’s Robotaxi Hype Fuels Bullish Price Targets to $500 S&P 500 All-Time Highs: 5 Catalysts Driving It Higher The Top Insider Sells From Q2: Buy, Sell, or Hold? 5 High-Yielding ETFs to Buy and Hold Forever Why BigBear.ai Could Rally 100% and Catch Palantir Soon Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
